Health Care & Life Sciences » Biotechnology | Organovo Holdings Inc.

Organovo Holdings Inc. | Mutual Funds

Mutual Funds that own Organovo Holdings Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
ARK Innovation ETF
9,159,530
8.07%
0
0.84%
09/05/2018
ARK Genomic Revolution Multi Sector ETF
3,566,787
3.14%
19,915
1.49%
09/05/2018
Vanguard Total Stock Market Index Fund
2,362,328
2.08%
0
0%
07/31/2018
iShares Russell 2000 ETF
2,344,416
2.06%
-1,251
0.01%
09/06/2018
2,154,283
1.9%
0
5.31%
09/05/2018
ARK Industrial Innovation ETF
1,766,129
1.56%
0
1.26%
09/05/2018
Vanguard Extended Market Index Fund
1,433,593
1.26%
0
0%
07/31/2018
iShares Russell 2000 Growth ETF
1,075,355
0.95%
0
0.01%
09/06/2018
Fidelity Spartan Extended Market Index Fund
472,846
0.42%
0
0%
07/31/2018
Fidelity Spartan Total Market Index Fund
337,362
0.3%
0
0%
07/31/2018

About Organovo Holdings

View Profile
Address
6275 Nancy Ridge Drive
San Diego California 92121
United States
Employees -
Website http://www.organovo.com
Updated 07/08/2019
Organovo Holdings, Inc. is a biotechnology company, which designs and creates functional and three-dimensional human tissues for medical research and therapeutic applications. It also develops and commercializes a platform technology for the generation of three-dimensional human tissues that can be employed in drug discovery and development, biological research, and as therapeutic implants for the treatment of damaged or degenerating tissues and organs. The company collaborates with pharmaceutical and academic partners to develop human biological disease models in three dimensions.